Haleon PLC

H6D0

Company Profile

  • Business description

    Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon’s brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

  • Contact

    The Heights
    Building 5, First Floor
    Surrey
    WeybridgeKT13 0NY
    GBR

    T: +44 1932959500

    E: [email protected]

    https://www.haleon.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    24,622

Stocks News & Analysis

stocks

Here’s how to value a share

Our best resources to help investors determine the value of a share.
stocks

How to avoid dividend disaster

Thinking about common reasons a company might stop paying a dividend can help income investors avoid disappointment.
stocks

GyG punished by market after solid earnings

Although Guzman y Gomez had solid earnings, it failed to meet lofty market expectations.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,245.0045.00-0.48%
CAC 407,839.02130.67-1.64%
DAX 4024,261.59101.50-0.42%
Dow JONES (US)45,447.23184.51-0.40%
FTSE 1009,321.4012.200.13%
HKSE25,829.91725.302.89%
NASDAQ21,559.1062.570.29%
Nikkei 22542,807.82197.650.46%
NZX 50 Index13,079.50114.57-0.87%
S&P 5006,464.132.78-0.04%
S&P/ASX 2008,972.4052.00-0.58%
SSE Composite Index3,883.5657.801.51%

Market Movers